TMCnet

U.S. FDA Grants Priority Review to Agios' sNDA for Mitapivat in Sickle Cell Disease

FDA’s PDUFA goal date is November 1, 2026; If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease; CAMBRIDGE, Mass., Ju ...
JD Supra

State Chatbot Laws Are Moving From Transparency to Risk Management

State chatbot laws are shifting from baseline transparency requirements to a more targeted, risk-based approach, with requirements that vary ...
IEEE

Design and Analysis of a High-Sensitivity Atomic Magnetic Gradiometer With Adjustable Baseline

Abstract: Optically pumped magnetometers (OPMs) can replace superconducting quantum interference devices (SQUIDs) as the core sensor for biomagnetic measurements. Among various types of atomic ...
IEEE

Equivalence Relation Analysis and Design of Repetitive Controllers and Multiple Quasi-Resonant Controllers for Single-Phase Inverters

Abstract: Repetitive controllers (RCs) and multiple quasi-resonant controllers (MQ-RSCs), both based on the internal model principle, are widely used in ac voltage/current control of single-phase ...